ArticleInternational journal of women's health2025
Network Analysis of Fear of Recurrence and Sleep Disorders in Ovarian Cancer Patients Undergoing Chemotherapy.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This quantitative study aimed to analyze the internal association mechanism between the core symptoms of fear of recurrence and sleep disturbances among ovarian cancer chemotherapy patients in Western Region of China. Methods: From October 2024 to July 2025, a convenience sampling method was used to administer a questionnaire to ovarian cancer chemotherapy patients at a gynecology center within a university hospital situated in the Northwest region of China. The investigation employed general information questionnaires, Pittsburgh Sleep Quality Index (PSQI) and Fear of Cancer Recurrence-Short Form (FCR-Q-SF) to conduct the survey. Use R language to construct a network visual map, calculate centrality indicators, and describe the relationships among symptoms. Results: This study included a total of 248 patients with ovarian cancer undergoing chemotherapy. The incidence rates of fear of recurrence and sleep disorders were 54.3% and 66.2%, respectively. Univariate analysis showed a positive correlation between patients' fear of cancer recurrence and sleep disorders (P<0.05). The core symptom in the fear of cancer recurrence network is "F10 worrying that medications will harm my body". The bridging node connecting symptoms across different dimensions is "F11 worrying about what will happen to my family if something happens to me". In the network of fear of recurrence and sleep disorders, the core symptoms are "F10 worrying that medications will harm my body", "S1 sleep latency", and "S6 sleep problems" in sequence. Additionally, "sleep problems" serves as the bridging node connecting symptoms of fear of recurrence and sleep disorders. Conclusion: The network structure of disease symptoms helps to gain an in-depth understanding of the mechanism of fear of cancer recurrence and its relationship with sleep disorders in ovarian cancer patients. Based on this, it is recommended that clinical practitioners prioritize the prevention and alleviation of patients' anxiety about medication-induced harm, and strengthen attention to sleep problems, so as to better improve their overall mental health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.